Who owns Orexigen Therapeutics?

Key details on Orexigen Therapeutics (Ticker: OREX)

Who owns Orexigen Therapeutics?

Is OREX a good stock to own? Find out who bought Orexigen Therapeutics, who sold Orexigen Therapeutics (OREX) stock, and who holds a large position in Orexigen Therapeutics.

Fund Name Number of Shares Share Valuation As Of
FMR 11.60M $57.41M June 30, 2015
STATE STREET CORPORATION 7.43M $36.79M June 30, 2015
T. Rowe Price Associates 6.61M $51.78M March 31, 2015
Vanguard 4.52M $22.39M June 30, 2015
BlackRock Fund Advisors 4.34M $21.46M June 30, 2015
S.A.C. Capital Advisors 4.30M $24.20M Dec. 31, 2013
Foresite Capital Management II 4.20M $32.89M March 31, 2015
Credit Suisse AG 4.02M $19.90M June 30, 2015
NEA Management Company 3.71M $18.36M June 30, 2015
Capital Research Global Investors^ 3.62M $28.34M March 31, 2015
Franklin Resources 3.45M $17.06M June 30, 2015
Samlyn Capital 3.14M $24.57M March 31, 2015
BlackRock Institutional Trust Company, N.A. 2.90M $14.37M June 30, 2015
Scale Management 2.88M $22.58M March 31, 2015
MORGAN STANLEY 2.87M $14.22M June 30, 2015
Partner Fund Management 2.87M $22.48M March 31, 2015
Deutsche Bank Aktiengesellschaft 2.87M $12.94M June 30, 2015
FIRST MANHATTAN 2.81M $17.37M June 30, 2014
Farallon Capital Management 2.68M $17.45M March 31, 2014
SUSQUEHANNA INTERNATIONAL 2.53M $10.77M Sept. 30, 2014
Millennium Management 2.50M $19.56M March 31, 2015
RS INVESTMENT MANAGEMENT 2.23M $9.50M Sept. 30, 2014
FIL 2.21M $14.34M March 31, 2014
Meditor 2.10M $12.87M Sept. 30, 2013
Bank of America Corporation 2.07M $10.25M June 30, 2015
Point72 Asset Management 2.05M $16.04M March 31, 2015
Visium Asset Management 2.00M $12.52M March 31, 2013
QVT Financial 1.99M $7.35M March 31, 2012
Palo Alto Investors 1.93M $9.56M June 30, 2015
Lamond Capital Partners 1.89M $11.46M Dec. 31, 2014

Who sold Orexigen Therapeutics?

Fund Name Date Sold Number of Shares Sold Share Valuation
Daniel D. Thurber Dec. 31, 2010 1.95M $15.79M